Ilyang Pharmaceutical Co.,Ltd (KRX: 007570)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,780
-80 (-0.74%)
Dec 20, 2024, 12:08 PM KST
-28.75%
Market Cap 197.43B
Revenue (ttm) 364.56B
Net Income (ttm) -737.67M
Shares Out 18.01M
EPS (ttm) -44.30
PE Ratio n/a
Forward PE n/a
Dividend 150.00 (1.37%)
Ex-Dividend Date Dec 27, 2024
Volume 16,680
Open 10,860
Previous Close 10,860
Day's Range 10,630 - 10,940
52-Week Range 9,820 - 16,080
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Feb 14, 2025

About Ilyang Pharmaceutical Co.,Ltd

Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and be... [Read more]

Sector Healthcare
Founded 1946
Employees 637
Stock Exchange Korea Stock Exchange
Ticker Symbol 007570
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.